4w7e

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (07:28, 27 September 2023) (edit) (undo)
 
(4 intermediate revisions not shown.)
Line 1: Line 1:
 +
==Crystal Structure of Full-Length Split GFP Mutant E124H/K126H With Copper Mediated Crystal Contacts, P 41 21 2 Space Group==
==Crystal Structure of Full-Length Split GFP Mutant E124H/K126H With Copper Mediated Crystal Contacts, P 41 21 2 Space Group==
-
<StructureSection load='4w7e' size='340' side='right' caption='[[4w7e]], [[Resolution|resolution]] 2.59&Aring;' scene=''>
+
<StructureSection load='4w7e' size='340' side='right'caption='[[4w7e]], [[Resolution|resolution]] 2.59&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4w7e]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4W7E OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4W7E FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4w7e]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4W7E OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4W7E FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CU:COPPER+(II)+ION'>CU</scene>, <scene name='pdbligand=IMD:IMIDAZOLE'>IMD</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.592&#8491;</td></tr>
-
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CRO:{2-[(1R,2R)-1-AMINO-2-HYDROXYPROPYL]-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL}ACETIC+ACID'>CRO</scene></td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CRO:{2-[(1R,2R)-1-AMINO-2-HYDROXYPROPYL]-4-(4-HYDROXYBENZYLIDENE)-5-OXO-4,5-DIHYDRO-1H-IMIDAZOL-1-YL}ACETIC+ACID'>CRO</scene>, <scene name='pdbligand=CU:COPPER+(II)+ION'>CU</scene>, <scene name='pdbligand=IMD:IMIDAZOLE'>IMD</scene></td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4w6a|4w6a]], [[4w6b|4w6b]], [[4w6c|4w6c]], [[4w6d|4w6d]], [[4w6f|4w6f]], [[4w6g|4w6g]], [[4w6h|4w6h]], [[4w6i|4w6i]], [[4w6j|4w6j]], [[4w6k|4w6k]], [[4w6l|4w6l]], [[4w6m|4w6m]], [[4w6n|4w6n]], [[4w6o|4w6o]], [[4w6p|4w6p]], [[4w6r|4w6r]], [[4w6s|4w6s]], [[4w6t|4w6t]], [[4w6u|4w6u]], [[4w72|4w72]], [[4w73|4w73]], [[4w74|4w74]], [[4w75|4w75]], [[4w76|4w76]], [[4w77|4w77]], [[4w7a|4w7a]], [[4w7c|4w7c]], [[4w7d|4w7d]], [[4w69|4w69]], [[4w7f|4w7f]], [[4w7r|4w7r]], [[4w7x|4w7x]]</td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4w7e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4w7e OCA], [https://pdbe.org/4w7e PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4w7e RCSB], [https://www.ebi.ac.uk/pdbsum/4w7e PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4w7e ProSAT]</span></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4w7e FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4w7e OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4w7e RCSB], [http://www.ebi.ac.uk/pdbsum/4w7e PDBsum]</span></td></tr>
+
</table>
</table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Applications ranging from synthetic biology to protein crystallization could be advanced by facile systems for connecting multiple proteins together in predefined spatial relationships. One approach to this goal is to engineer many distinct assembly forms of a single carrier protein or scaffold, to which other proteins of interest can then be readily attached. In this work we chose GFP as a scaffold and engineered many alternative oligomeric forms, driven by either specific disulfide bond formation or metal ion addition. We generated a wide range of spatial arrangements of GFP subunits from 11 different oligomeric variants, and determined their X-ray structures in a total of 33 distinct crystal forms. Some of the oligomeric GFP variants show geometric polymorphism depending on conditions, while others show considerable geometric rigidity. Potential future applications of this system are discussed.
 +
 +
A Suite of Engineered GFP Molecules for Oligomeric Scaffolding.,Leibly DJ, Arbing MA, Pashkov I, DeVore N, Waldo GS, Terwilliger TC, Yeates TO Structure. 2015 Sep 1;23(9):1754-68. doi: 10.1016/j.str.2015.07.008. Epub 2015, Aug 13. PMID:26278175<ref>PMID:26278175</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 4w7e" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Leibly, D J]]
+
[[Category: Large Structures]]
-
[[Category: Waldo, G S]]
+
[[Category: Synthetic construct]]
-
[[Category: Yeates, T O]]
+
[[Category: Leibly DJ]]
-
[[Category: Fluorescent protein]]
+
[[Category: Waldo GS]]
 +
[[Category: Yeates TO]]

Current revision

Crystal Structure of Full-Length Split GFP Mutant E124H/K126H With Copper Mediated Crystal Contacts, P 41 21 2 Space Group

PDB ID 4w7e

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4w7e"
Personal tools